Laboratorio Reig Jofre, S.A. (RJF.MC)
EUR 2.91
(0.69%)
EUR 2.91
(0.69%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.12 EUR | 20.0% |
| 2022 | 0.10 EUR | 51.06% |
| 2021 | 0.07 EUR | -10.9% |
| 2020 | 0.07 EUR | 7.22% |
| 2019 | 0.07 EUR | -50.5% |
| 2018 | 0.14 EUR | 0.0% |
| 2017 | 0.14 EUR | 16.67% |
| 2016 | 0.12 EUR | 1100.0% |
| 2015 | 0.01 EUR | -94.12% |
| 2014 | 0.17 EUR | 183.33% |
| 2013 | 0.06 EUR | 15100.0% |
| 2012 | -0.00 EUR | -100.04% |
| 2011 | 1.00 EUR | 171.94% |
| 2010 | -1.39 EUR | 50.0% |
| 2009 | -2.78 EUR | -2880.0% |
| 2008 | 0.10 EUR | -83.33% |
| 2007 | 0.60 EUR | 50.0% |
| 2006 | 0.40 EUR | 0.0% |
| 2005 | 0.40 EUR | 21.21% |
| 2004 | 0.33 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.03 EUR | 9.15% |
| 2024 Q1 | 0.04 EUR | 113.4% |
| 2024 Q2 | 0.03 EUR | -31.4% |
| 2023 Q1 | 0.05 EUR | 0.0% |
| 2023 Q3 | 0.03 EUR | 18.3% |
| 2023 FY | - EUR | 20.0% |
| 2023 Q2 | 0.02 EUR | -52.24% |
| 2023 Q4 | 0.02 EUR | -30.22% |
| 2022 Q4 | 0.05 EUR | 5366.67% |
| 2022 FY | - EUR | 51.06% |
| 2022 Q3 | 0.00 EUR | 0.0% |
| 2021 Q3 | 0.02 EUR | 1791.67% |
| 2021 Q2 | -0.00 EUR | -102.5% |
| 2021 Q1 | 0.05 EUR | 1016.28% |
| 2021 FY | - EUR | -10.9% |
| 2021 Q4 | -0.00 EUR | -101.48% |
| 2020 Q3 | 0.02 EUR | 153.33% |
| 2020 FY | - EUR | 7.22% |
| 2020 Q1 | 0.04 EUR | 24.0% |
| 2020 Q2 | 0.01 EUR | -82.72% |
| 2020 Q4 | 0.00 EUR | -77.37% |
| 2019 Q1 | 0.04 EUR | -51.79% |
| 2019 FY | - EUR | -50.5% |
| 2019 Q4 | 0.04 EUR | 436.54% |
| 2019 Q3 | -0.01 EUR | -225.3% |
| 2019 Q2 | 0.01 EUR | -77.93% |
| 2018 FY | - EUR | 0.0% |
| 2018 Q1 | 0.04 EUR | -64.9% |
| 2018 Q4 | 0.08 EUR | 310.53% |
| 2018 Q3 | 0.02 EUR | 72.73% |
| 2018 Q2 | 0.01 EUR | -68.66% |
| 2017 FY | - EUR | 16.67% |
| 2017 Q4 | 0.10 EUR | 1854.39% |
| 2017 Q3 | -0.01 EUR | -151.82% |
| 2017 Q2 | 0.01 EUR | -66.77% |
| 2017 Q1 | 0.03 EUR | -21.19% |
| 2016 Q3 | 0.03 EUR | 28.57% |
| 2016 Q4 | 0.04 EUR | 55.56% |
| 2016 FY | - EUR | 1100.0% |
| 2016 Q1 | 0.03 EUR | 3800.0% |
| 2016 Q2 | 0.02 EUR | -32.69% |
| 2015 FY | - EUR | -94.12% |
| 2015 Q2 | 0.03 EUR | -64.07% |
| 2015 Q3 | 0.02 EUR | -20.0% |
| 2015 Q4 | 0.00 EUR | -96.67% |
| 2015 Q1 | 0.08 EUR | 2555.88% |
| 2014 Q1 | 0.15 EUR | 302.16% |
| 2014 FY | - EUR | 183.33% |
| 2014 Q4 | -0.00 EUR | -116.19% |
| 2014 Q3 | 0.02 EUR | 201.45% |
| 2014 Q2 | -0.02 EUR | -113.8% |
| 2013 Q3 | -0.01 EUR | 58.09% |
| 2013 Q4 | -0.07 EUR | -484.25% |
| 2013 FY | - EUR | 15100.0% |
| 2013 Q1 | 0.18 EUR | -70.0% |
| 2013 Q2 | -0.03 EUR | -116.83% |
| 2012 Q1 | 0.13 EUR | -87.0% |
| 2012 Q2 | -0.74 EUR | -669.23% |
| 2012 Q3 | 0.58 EUR | 178.38% |
| 2012 Q4 | 0.60 EUR | 3.45% |
| 2012 FY | - EUR | -100.04% |
| 2011 Q1 | 0.14 EUR | 0.0% |
| 2011 Q4 | 1.00 EUR | 0.0% |
| 2011 FY | - EUR | 171.94% |
| 2011 Q2 | -0.08 EUR | -158.57% |
| 2010 Q1 | 0.11 EUR | 0.0% |
| 2010 Q2 | -0.06 EUR | -154.45% |
| 2010 FY | - EUR | 50.0% |
| 2009 Q1 | 0.06 EUR | 0.0% |
| 2009 FY | - EUR | -2880.0% |
| 2008 FY | - EUR | -83.33% |
| 2007 FY | - EUR | 50.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 21.21% |
| 2004 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Almirall, S.A. | -0.20 EUR | 160.0% |
| Faes Farma, S.A. | 0.30 EUR | 60.0% |